Federal Court Dismisses Fresenius Claims in Patent Dispute Over IV Calcium Bags

In a recent decision, a Delaware federal judge ruled against Fresenius, a prominent player in the medical sector, in a legal battle concerning the sale of IV bags containing calcium supplements intended for the treatment of hypocalcemia. Fresenius had alleged questionable conduct in the patent process by their adversary but failed to persuade the court of any inequitable conduct. The ruling is a significant turn in the patent dispute, underscoring the meticulous burden of proof required to establish misconduct in patent prosecution within the judicial system.